Global Biologics Drug Development Market Size, Status and Forecast 2024-2031

Report ID: 917646 | Published Date: Jan 2025 | No. of Page: 97 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Biologics Drug Development Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Clinical Manufacturing
        1.2.3 Formulation Development
        1.2.4 Bioassay Development
        1.2.5 Analytical Services
    1.3 Market by Application
        1.3.1 Global Biologics Drug Development Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 In-House
        1.3.3 Outsource
        1.3.4 Pharma Excess
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Biologics Drug Development Market Perspective (2016-2027)
    2.2 Biologics Drug Development Growth Trends by Regions
        2.2.1 Biologics Drug Development Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Biologics Drug Development Historic Market Share by Regions (2016-2021)
        2.2.3 Biologics Drug Development Forecasted Market Size by Regions (2022-2027)
    2.3 Biologics Drug Development Industry Dynamic
        2.3.1 Biologics Drug Development Market Trends
        2.3.2 Biologics Drug Development Market Drivers
        2.3.3 Biologics Drug Development Market Challenges
        2.3.4 Biologics Drug Development Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Biologics Drug Development Players by Revenue
        3.1.1 Global Top Biologics Drug Development Players by Revenue (2016-2021)
        3.1.2 Global Biologics Drug Development Revenue Market Share by Players (2016-2021)
    3.2 Global Biologics Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Biologics Drug Development Revenue
    3.4 Global Biologics Drug Development Market Concentration Ratio
        3.4.1 Global Biologics Drug Development Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Biologics Drug Development Revenue in 2020
    3.5 Biologics Drug Development Key Players Head office and Area Served
    3.6 Key Players Biologics Drug Development Product Solution and Service
    3.7 Date of Enter into Biologics Drug Development Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Biologics Drug Development Breakdown Data by Type
    4.1 Global Biologics Drug Development Historic Market Size by Type (2016-2021)
    4.2 Global Biologics Drug Development Forecasted Market Size by Type (2022-2027)

5 Biologics Drug Development Breakdown Data by Application
    5.1 Global Biologics Drug Development Historic Market Size by Application (2016-2021)
    5.2 Global Biologics Drug Development Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Biologics Drug Development Market Size (2016-2027)
    6.2 North America Biologics Drug Development Market Size by Type
        6.2.1 North America Biologics Drug Development Market Size by Type (2016-2021)
        6.2.2 North America Biologics Drug Development Market Size by Type (2022-2027)
        6.2.3 North America Biologics Drug Development Market Size by Type (2016-2027)
    6.3 North America Biologics Drug Development Market Size by Application
        6.3.1 North America Biologics Drug Development Market Size by Application (2016-2021)
        6.3.2 North America Biologics Drug Development Market Size by Application (2022-2027)
        6.3.3 North America Biologics Drug Development Market Size by Application (2016-2027)
    6.4 North America Biologics Drug Development Market Size by Country
        6.4.1 North America Biologics Drug Development Market Size by Country (2016-2021)
        6.4.2 North America Biologics Drug Development Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Biologics Drug Development Market Size (2016-2027)
    7.2 Europe Biologics Drug Development Market Size by Type
        7.2.1 Europe Biologics Drug Development Market Size by Type (2016-2021)
        7.2.2 Europe Biologics Drug Development Market Size by Type (2022-2027)
        7.2.3 Europe Biologics Drug Development Market Size by Type (2016-2027)
    7.3 Europe Biologics Drug Development Market Size by Application
        7.3.1 Europe Biologics Drug Development Market Size by Application (2016-2021)
        7.3.2 Europe Biologics Drug Development Market Size by Application (2022-2027)
        7.3.3 Europe Biologics Drug Development Market Size by Application (2016-2027)
    7.4 Europe Biologics Drug Development Market Size by Country
        7.4.1 Europe Biologics Drug Development Market Size by Country (2016-2021)
        7.4.2 Europe Biologics Drug Development Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Biologics Drug Development Market Size (2016-2027)
    8.2 Asia-Pacific Biologics Drug Development Market Size by Type
        8.2.1 Asia-Pacific Biologics Drug Development Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Biologics Drug Development Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Biologics Drug Development Market Size by Type (2016-2027)
    8.3 Asia-Pacific Biologics Drug Development Market Size by Application
        8.3.1 Asia-Pacific Biologics Drug Development Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Biologics Drug Development Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Biologics Drug Development Market Size by Application (2016-2027)
    8.4 Asia-Pacific Biologics Drug Development Market Size by Region
        8.4.1 Asia-Pacific Biologics Drug Development Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Biologics Drug Development Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Biologics Drug Development Market Size (2016-2027)
    9.2 Latin America Biologics Drug Development Market Size by Type
        9.2.1 Latin America Biologics Drug Development Market Size by Type (2016-2021)
        9.2.2 Latin America Biologics Drug Development Market Size by Type (2022-2027)
        9.2.3 Latin America Biologics Drug Development Market Size by Type (2016-2027)
    9.3 Latin America Biologics Drug Development Market Size by Application
        9.3.1 Latin America Biologics Drug Development Market Size by Application (2016-2021)
        9.3.2 Latin America Biologics Drug Development Market Size by Application (2022-2027)
        9.3.3 Latin America Biologics Drug Development Market Size by Application (2016-2027)
    9.4 Latin America Biologics Drug Development Market Size by Country
        9.4.1 Latin America Biologics Drug Development Market Size by Country (2016-2021)
        9.4.2 Latin America Biologics Drug Development Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Biologics Drug Development Market Size (2016-2027)
    10.2 Middle East & Africa Biologics Drug Development Market Size by Type
        10.2.1 Middle East & Africa Biologics Drug Development Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Biologics Drug Development Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Biologics Drug Development Market Size by Type (2016-2027)
    10.3 Middle East & Africa Biologics Drug Development Market Size by Application
        10.3.1 Middle East & Africa Biologics Drug Development Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Biologics Drug Development Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Biologics Drug Development Market Size by Application (2016-2027)
    10.4 Middle East & Africa Biologics Drug Development Market Size by Country
        10.4.1 Middle East & Africa Biologics Drug Development Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Biologics Drug Development Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbvie
        11.1.1 Abbvie Company Details
        11.1.2 Abbvie Business Overview
        11.1.3 Abbvie Biologics Drug Development Introduction
        11.1.4 Abbvie Revenue in Biologics Drug Development Business (2016-2021)
        11.1.5 Abbvie Recent Development
    11.2 Allergan
        11.2.1 Allergan Company Details
        11.2.2 Allergan Business Overview
        11.2.3 Allergan Biologics Drug Development Introduction
        11.2.4 Allergan Revenue in Biologics Drug Development Business (2016-2021)
        11.2.5 Allergan Recent Development
    11.3 Boehringer Ingelheim
        11.3.1 Boehringer Ingelheim Company Details
        11.3.2 Boehringer Ingelheim Business Overview
        11.3.3 Boehringer Ingelheim Biologics Drug Development Introduction
        11.3.4 Boehringer Ingelheim Revenue in Biologics Drug Development Business (2016-2021)
        11.3.5 Boehringer Ingelheim Recent Development
    11.4 Charles River Laboratories
        11.4.1 Charles River Laboratories Company Details
        11.4.2 Charles River Laboratories Business Overview
        11.4.3 Charles River Laboratories Biologics Drug Development Introduction
        11.4.4 Charles River Laboratories Revenue in Biologics Drug Development Business (2016-2021)
        11.4.5 Charles River Laboratories Recent Development
    11.5 Catalent
        11.5.1 Catalent Company Details
        11.5.2 Catalent Business Overview
        11.5.3 Catalent Biologics Drug Development Introduction
        11.5.4 Catalent Revenue in Biologics Drug Development Business (2016-2021)
        11.5.5 Catalent Recent Development
    11.6 Lonza Group
        11.6.1 Lonza Group Company Details
        11.6.2 Lonza Group Business Overview
        11.6.3 Lonza Group Biologics Drug Development Introduction
        11.6.4 Lonza Group Revenue in Biologics Drug Development Business (2016-2021)
        11.6.5 Lonza Group Recent Development
    11.7 Amgen
        11.7.1 Amgen Company Details
        11.7.2 Amgen Business Overview
        11.7.3 Amgen Biologics Drug Development Introduction
        11.7.4 Amgen Revenue in Biologics Drug Development Business (2016-2021)
        11.7.5 Amgen Recent Development
    11.8 Sanofi
        11.8.1 Sanofi Company Details
        11.8.2 Sanofi Business Overview
        11.8.3 Sanofi Biologics Drug Development Introduction
        11.8.4 Sanofi Revenue in Biologics Drug Development Business (2016-2021)
        11.8.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Biologics Drug Development Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Clinical Manufacturing
    Table 3. Key Players of Formulation Development
    Table 4. Key Players of Bioassay Development
    Table 5. Key Players of Analytical Services
    Table 6. Global Biologics Drug Development Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Biologics Drug Development Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Biologics Drug Development Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Biologics Drug Development Market Share by Regions (2016-2021)
    Table 10. Global Biologics Drug Development Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Biologics Drug Development Market Share by Regions (2022-2027)
    Table 12. Biologics Drug Development Market Trends
    Table 13. Biologics Drug Development Market Drivers
    Table 14. Biologics Drug Development Market Challenges
    Table 15. Biologics Drug Development Market Restraints
    Table 16. Global Biologics Drug Development Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Biologics Drug Development Market Share by Players (2016-2021)
    Table 18. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2020)
    Table 19. Ranking of Global Top Biologics Drug Development Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Biologics Drug Development Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Biologics Drug Development Product Solution and Service
    Table 23. Date of Enter into Biologics Drug Development Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Biologics Drug Development Revenue Market Share by Type (2016-2021)
    Table 27. Global Biologics Drug Development Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Biologics Drug Development Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Biologics Drug Development Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Biologics Drug Development Revenue Market Share by Application (2016-2021)
    Table 31. Global Biologics Drug Development Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Biologics Drug Development Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Biologics Drug Development Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Biologics Drug Development Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Biologics Drug Development Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Biologics Drug Development Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Biologics Drug Development Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Biologics Drug Development Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Biologics Drug Development Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Biologics Drug Development Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Biologics Drug Development Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Biologics Drug Development Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Biologics Drug Development Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Biologics Drug Development Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Biologics Drug Development Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Biologics Drug Development Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Biologics Drug Development Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Biologics Drug Development Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Biologics Drug Development Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Biologics Drug Development Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Biologics Drug Development Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Biologics Drug Development Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Biologics Drug Development Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Biologics Drug Development Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Biologics Drug Development Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Biologics Drug Development Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Biologics Drug Development Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Biologics Drug Development Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Abbvie Company Details
    Table 64. Abbvie Business Overview
    Table 65. Abbvie Biologics Drug Development Product
    Table 66. Abbvie Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 67. Abbvie Recent Development
    Table 68. Allergan Company Details
    Table 69. Allergan Business Overview
    Table 70. Allergan Biologics Drug Development Product
    Table 71. Allergan Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 72. Allergan Recent Development
    Table 73. Boehringer Ingelheim Company Details
    Table 74. Boehringer Ingelheim Business Overview
    Table 75. Boehringer Ingelheim Biologics Drug Development Product
    Table 76. Boehringer Ingelheim Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 77. Boehringer Ingelheim Recent Development
    Table 78. Charles River Laboratories Company Details
    Table 79. Charles River Laboratories Business Overview
    Table 80. Charles River Laboratories Biologics Drug Development Product
    Table 81. Charles River Laboratories Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 82. Charles River Laboratories Recent Development
    Table 83. Catalent Company Details
    Table 84. Catalent Business Overview
    Table 85. Catalent Biologics Drug Development Product
    Table 86. Catalent Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 87. Catalent Recent Development
    Table 88. Lonza Group Company Details
    Table 89. Lonza Group Business Overview
    Table 90. Lonza Group Biologics Drug Development Product
    Table 91. Lonza Group Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 92. Lonza Group Recent Development
    Table 93. Amgen Company Details
    Table 94. Amgen Business Overview
    Table 95. Amgen Biologics Drug Development Product
    Table 96. Amgen Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 97. Amgen Recent Development
    Table 98. Sanofi Company Details
    Table 99. Sanofi Business Overview
    Table 100. Sanofi Revenue in Biologics Drug Development Business (2016-2021) & (US$ Million)
    Table 101. Sanofi Recent Development
    Table 102. Research Programs/Design for This Report
    Table 103. Key Data Information from Secondary Sources
    Table 104. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Biologics Drug Development Market Share by Type: 2020 VS 2027
    Figure 2. Clinical Manufacturing Features
    Figure 3. Formulation Development Features
    Figure 4. Bioassay Development Features
    Figure 5. Analytical Services Features
    Figure 6. Global Biologics Drug Development Market Share by Application: 2020 VS 2027
    Figure 7. In-House Case Studies
    Figure 8. Outsource Case Studies
    Figure 9. Pharma Excess Case Studies
    Figure 10. Biologics Drug Development Report Years Considered
    Figure 11. Global Biologics Drug Development Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Biologics Drug Development Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Biologics Drug Development Market Share by Regions: 2020 VS 2027
    Figure 14. Global Biologics Drug Development Market Share by Regions (2022-2027)
    Figure 15. Global Biologics Drug Development Market Share by Players in 2020
    Figure 16. Global Top Biologics Drug Development Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Drug Development as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Biologics Drug Development Revenue in 2020
    Figure 18. Global Biologics Drug Development Revenue Market Share by Type (2016-2021)
    Figure 19. Global Biologics Drug Development Revenue Market Share by Type (2022-2027)
    Figure 20. North America Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Biologics Drug Development Market Share by Type (2016-2027)
    Figure 22. North America Biologics Drug Development Market Share by Application (2016-2027)
    Figure 23. North America Biologics Drug Development Market Share by Country (2016-2027)
    Figure 24. United States Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Biologics Drug Development Market Share by Type (2016-2027)
    Figure 28. Europe Biologics Drug Development Market Share by Application (2016-2027)
    Figure 29. Europe Biologics Drug Development Market Share by Country (2016-2027)
    Figure 30. Germany Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Biologics Drug Development Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Biologics Drug Development Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Biologics Drug Development Market Share by Region (2016-2027)
    Figure 40. China Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Biologics Drug Development Market Share by Type (2016-2027)
    Figure 48. Latin America Biologics Drug Development Market Share by Application (2016-2027)
    Figure 49. Latin America Biologics Drug Development Market Share by Country (2016-2027)
    Figure 50. Mexico Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Biologics Drug Development Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Biologics Drug Development Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Biologics Drug Development Market Share by Country (2016-2027)
    Figure 56. Turkey Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Biologics Drug Development Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Abbvie Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 60. Allergan Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 61. Boehringer Ingelheim Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 62. Charles River Laboratories Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 63. Catalent Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 64. Lonza Group Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 65. Amgen Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 66. Sanofi Revenue Growth Rate in Biologics Drug Development Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbvie
Allergan
Boehringer Ingelheim
Charles River Laboratories
Catalent
Lonza Group
Amgen
Sanofi
Frequently Asked Questions
Biologics Drug Development report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Biologics Drug Development report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Biologics Drug Development report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports